In breast cancer, downregulation of PTEN occurs frequently, especially in poor-prognosis triple-negative breast cancer (TNBC) without any evidence of genetic alteration of the PTEN locus in most cases28,29. This evidence concerns the gene PTEN and triple-negative breast carcinoma.